SORRENTO THERAPEUTICS INCSORRENTO THERAPEUTICS INCSORRENTO THERAPEUTICS INC

SORRENTO THERAPEUTICS INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.43 M‬USD
‪542.68 M‬
Beta (1Y)
−19.54

About SORRENTO THERAPEUTICS INC


CEO
Henry H. Ji
Headquarters
San Diego
Founded
1989
FIGI
BBG000BDM2G2
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of SRNE is 0.0036 USD — it has decreased by −18.18% in the past 24 hours. Watch SORRENTO THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange SORRENTO THERAPEUTICS INC stocks are traded under the ticker SRNE.
SRNE stock has risen by 500.00% compared to the previous week, the month change is a 620.00% rise, over the last year SORRENTO THERAPEUTICS INC has showed a −96.11% decrease.
SRNE reached its all-time high on Feb 15, 2007 with the price of 187,500.0000 USD, and its all-time low was 0.0001 USD and was reached on Apr 24, 2024. View more price dynamics on SRNE chart.
See other stocks reaching their highest and lowest prices.
SRNE stock is 650.00% volatile and has beta coefficient of −19.54. Track SORRENTO THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is SORRENTO THERAPEUTICS INC there?
Today SORRENTO THERAPEUTICS INC has the market capitalization of ‪2.43 M‬, it has increased by 17.65% over the last week.
Yes, you can track SORRENTO THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
SORRENTO THERAPEUTICS INC is going to release the next earnings report on Nov 8, 2024. Keep track of upcoming events with our Earnings Calendar.
No, SRNE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SRNE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SORRENTO THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SORRENTO THERAPEUTICS INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SORRENTO THERAPEUTICS INC stock shows the sell signal. See more of SORRENTO THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.